They say the market is smarter than you...

The "efficient-market hypothesis" boils down to this claim: If you know something, everybody else probably knows it too.

For example, you may think one company has a bright future while another is doomed. But the theory claims that if you've figured this out, so has everyone else. Thus, the market prices the stock accordingly.

That's how the theory goes at least.

The way I see things, it's not possible. Of course you know things that almost nobody else knows.

Take me, for example... I've had a wide-ranging career. I know a lot about medicine – particularly ophthalmology. I've been an entrepreneur, so I know the risks and rewards of starting a business. I have some good insights into the wine and beverage markets. I know how to run a public company. And I even know something about how popular Venezuelan food is in the American Southeast.

You know things, too... Whether it's about movie box-office numbers, golfing equipment, or a new tool used at your job, I'm sure you know things that many other people don't.

You can use that knowledge to profit.

Remember, we're not just trading ticker symbols. Stocks represent tiny ownership stakes in real, operating businesses. So to argue that everyone knows what matters in these businesses just isn't true.

I've seen articles and medical journals that pointed to a clear investment opportunity in a stock. But even though the information was out there for anyone who wanted to read it, the stock didn't move until it was covered by 60 Minutes or the mainstream media.

So yes, you do know things that can help you earn money in the market. You just need to put that knowledge to work.

If you've been reading my stuff for any length of time, you've seen me quote Peter Lynch. The legendary fund manager directed the Fidelity Magellan Fund from 1977 to 1990. He posted a seemingly impossible annual return of 29% during his time there.

Lynch's central thesis is that you can know and see things that Wall Street can't. He calls it "the power of common knowledge." Here's an example from Lynch...

I had a great luck company called Hanes. They test marketed a product called L'Eggs in Boston and I think in Columbus, Ohio, maybe three or four markets. And [Lynch's wife] Carolyn brought this product home... and she said, "It's great." And she almost got a black belt in shopping...

She's a very good shopper and she would buy these things. She said, "They're really great." And I did a little bit of research. I found out the average woman goes to the supermarket or a drugstore once a week. And they go to a woman's specialty store or department store once every six weeks. And all the good hosiery, all the good pantyhose is being sold in department stores. They were selling junk in the supermarkets. They were selling junk in the drugstores.

So this company came up with a product. They rack-jobbed it, they had all the sizes, all the fits... They never advertised price. They just advertised "This fits. You'll enjoy it." And it was a huge success and it became my biggest position.

Lynch went on to make many multiples of his money on Hanes... all because his wife was a customer.

Now, to be clear, there's more to successful investing. You need to understand how companies make money, how their shares are valued, and what the market currently expects from them. You shouldn't put your life savings into one stock just because you like the company's product.

However, all investors are searching for an edge. If you have real-world knowledge about what consumers are out there doing, that's an edge right there.

And if you want a system for finding winning stocks built around real-world indicators, then I suggest you check out Stansberry Research's new Shadow Data Indicator ("SDI").

This system follows real people who are using real technology in real time. And it uses trends in their behavior to form an investment thesis.

For instance, well before the average investor knows anything about a new breakthrough technology, software developers are already testing it, building on top of it, and sharing it with each other.

That activity leaves a trail of data. The SDI tracks that trail. And when the technology crosses three critical thresholds, it triggers a buy signal... before any of it shows up in the headlines.

In a back test, the SDI could have turned $10,000 into more than $600,000 since December 2017. Now, it's ready to help you book a series of double- and triple-digit returns – regardless of what the market does next.

If you want to learn more about the SDI and the exciting new editor behind it, then I suggest you check out this recent presentation.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
April 8, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top